Healthcare / Medical Care FacilitiesTokyo
$799.00
+2.00 (+0.25%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $-3.1B · quality 25.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$23.4B
P/E
8.2x
↓EV/EBITDA
6.6x
↓ROE
10.5%
↑Gross Margin
49.3%
↑Debt/Equity
1.47
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.0%
FCF CAGR
—
FCF margin
-6.6%
FCF / Net income
-0.98x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $47.04B · net income $3.13B · FCF $-3.08B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $47.04B | $47.04B | $33.02B | $35.21B | $35.31B |
| Net Income | $3.13B | $3.13B | $2.60B | $2.42B | $2.71B |
| EBITDA | $9.04B | $9.04B | $6.23B | $4.95B | $4.79B |
| EPS | 106.81 | 106.81 | 93.99 | 113.91 | 129.71 |
| Gross Margin | 49.3% | 49.3% | 48.2% | 39.1% | 40.3% |
| Operating Margin | 11.4% | 11.4% | 11.3% | 10.5% | 10.4% |
| Net Margin | 6.7% | 6.7% | 7.9% | 6.9% | 7.7% |
| Balance Sheet | |||||
| Debt/Equity | 1.47 | 1.47 | 0.98 | 1.83 | 1.58 |
| Current Ratio | 2.03 | 2.03 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.08B | $-3.08B | $-747.0M | $-3.23B | $5.77B |
| Returns | |||||
| ROE | 10.5% | 10.5% | 9.5% | 20.7% | 28.6% |
| Valuation | |||||
| P/E | 8.21 | 8.21 | 27.45 | — | — |
| EV/EBITDA | 6.57 | 6.57 | 14.40 | — | — |
| P/B | 0.79 | 0.79 | 2.61 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 42.4% | 42.4% | -6.2% | -0.3% | — |
| EPS Growth | 13.6% | 13.6% | -17.5% | -12.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-12.8%
EPS terminal req.
$70.90
Spread vs growth
26.4%
5Y implied EPS CAGR
-4.3%
EPS terminal req.
$85.79
Spread vs growth
17.9%
10Y implied EPS CAGR
2.6%
EPS terminal req.
$138.16
Spread vs growth
11.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-21.0%
Start / end P/E
11.0x → 7.6x
EPS bridge
93.99 → 106.81
Residual
-4.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.